At Virupaksha, delivering excellence in pharmaceutical manufacturing is not just a goal; it’s an unwavering commitment to quality and innovation. Renowned for producing high-purity Fluconazole, our facilities are meticulously crafted to meet the stringent standards set by WHO-GMP, ensuring that every batch reflects our dedication to global health. Our adherence to ISO 9001 guarantees that we maintain a robust quality management system, while ISO 14001 highlights our commitment to environmentally sustainable practices throughout the production process.
This meticulous attention to detail is particularly crucial given Fluconazole’s vital role in treating cryptococcal meningitis—a life-threatening condition affecting immunocompromised patients worldwide. With each step of our manufacturing process steeped in scientific rigor and ethical responsibility, Virupaksha stands at the forefront of pharmaceutical excellence, dedicated to making a profound impact on patient care globally.
Other Latest News
- India News | North Gujarat Drives 12% of State's Pharmaceutical Output, Eyes Global Expansion September 1, 2025 3:06 pm Latestly Gandhinagar (Gujarat) [India], September 1 (ANI): Gujarat is contributing to India's pharmaceutical sector's growth, anchored by supportive government initiatives and investment opportunities. It is home to global companies such as Sun Pharma, …
- Top stocks in news: Paytm, Adani Power, BHEL, Auro Pharma, BEML, Nazara Tech, NCC, HEG September 1, 2025 4:36 am Business Today Indian benchmark indices settled lower on Friday as the markets further assessed the full impact of US tariffs and FIIs outflows. BSE Sensex tanked 270.92 points, or 0.34 per cent, to settle at 79,809.65, while NSE's Nifty50 declined 74.05 points, or 0 …
- The US-EU face-off over pharma is on pause—for now August 27, 2025 7:23 pm Atlantic Council New Atlanticist August 27, 2025 • 2:54 pm ET Print this page By Emma Nix After months of tough negotiations, the United States and the European Union (EU) settled on the fine print of a transatlantic trade deal on July 27. The deal locks in US tariffs on …
- Pharma stocks take a hit as Trump issues fresh warning; key details August 26, 2025 6:30 am Business Today Pharma stocks tumbled on Tuesday after the US President Donald Trump vowed to slash drug prices in the US by an unprecedented 1,400–1,500 per cent, (practically not possible below 100 per cent), a move that could render exports to the US uncompetitive. …
- Business News | Akums and The Govt of The Republic of Zambia Announce Joint Venture to Establish Pharmaceutical Manufacturing Facility in Zambia August 23, 2025 12:51 pm Latestly NewsVoir Lusaka [Zambia]/ New Delhi [India], August 23: Akums, a leading player in pharmaceutical manufacturing, and The Government of The Republic of Zambia (GRZ), have announced a partnership to set up a manufacturing facility in Zambia to provide …
- Pharma Pulse: US API Stockpile Plan, Mounjaro Price Hike in UK, and New Data on Vaccine Safety August 16, 2025 1:52 am Pharmaceutical Commerce Welcome to Pharma Pulse, a Pharmaceutical Commerce podcast where we bring you the latest insights shaping patient access, supply chain/logistics, data & tech, and healthcare innovation. I’m your host, and today we’re covering three major …
- Fierce Pharma Asia—Padcev's new breakthrough; China Alzheimer's drug's fate; Fosun's DPP1 deal August 15, 2025 9:08 pm Fierce Pharma The combination of Padcev and Keytruda delivered a phase 3 win in muscle-invasive bladder cancer. China did not renew the conditional approval for a controversial Alzheimer's disease drug. Fosun Pharma is out-licensing its DPP1 inhibitor for up to $645 …
- Pharma Pulse: AbbVie Boosts Domestic API Manufacturing, Supermarkets Lead in Pharmacy Satisfaction, and GLP-1 Coverage Tightens August 15, 2025 1:52 am Pharmaceutical Commerce Welcome to Pharma Pulse, a Pharmaceutical Commerce podcast where we bring you the latest insights shaping patient access, supply chain/logistics, data & tech, and healthcare innovation.I’m your host, and today we’re covering three key developments— …
- Trump Executive Order Launches Six-Month API Stockpile to Boost US Drug Supply Chain Resilience August 14, 2025 11:29 pm Pharmaceutical Executive Yesterday, President Trump signed an executive order (EO) that’s intended to provide a resilient domestic supply chain for essential medicines in the United States, as first reported by Reuters.1 This would involve filling the Strategic Active …
- Stay away from pharma stocks amid India-US uncertainty: Mitesh Panchal August 14, 2025 6:34 am Business Today Sebi-registered analyst Mitesh Panchal on Thursday told Business Today that the pharma sector continues to face a fundamental overhang due to tensions between India and the US. "After the recent correction, many stocks are available at attractive …
- AbbVie Invests $195 Million to Expand Stateside API Manufacturing August 13, 2025 11:57 pm Pharmaceutical Commerce Image Credit: Adobe Stock Images/MichaelVi.com AbbVie is investing $195 million investment into its North Chicago, IL manufacturing facility as the company looks to grow its domestic active pharmaceutical ingredient (API) production in the United …
- AbbVie Latest to Commit to New US Manufacturing Growth Projects, Committing $195 Million to Expand API Capabilities August 13, 2025 10:08 pm Pharmaceutical Executive Topline Findings AbbVie Investment: AbbVie commits $195 million to expand active pharmaceutical ingredient manufacturing at its North Chicago facility, supporting next-generation neuroscience, immunology, and oncology medicines. US Manufacturing Boost: …
- Compounding Pharmacy Market and Pharma Manufacturing Poised for Strong, Parallel Growth by 2030 | Mordor Intelligence August 11, 2025 3:14 pm WFMZ - Pennsylvania HYDERABAD, India, Aug. 11, 2025 /PRNewswire/ -- Mordor Intelligence recently released comprehensive reports on compounding pharmacy market and pharma manufacturing industry, detailing robust growth trajectories for both sectors. Driven by …
- Indian API maker Garonit Pharma plans $46.1M antiseptic product plant in New York August 7, 2025 2:37 pm Fierce Pharma Garonit Pharmaceutical, an India-based API maker, plans to build a $46.1 million production plant in New York to produce chlorhexidine gluconate, which is primarily used as an antiseptic and surgical disinfectant. The company, which was founded in 1994, is …
- Business News | Trump's Tariff Move on India May Backfire, Say Pharma Industry Leaders July 31, 2025 8:22 am Latestly New Delhi [India], July 31 (ANI): The Indian pharmaceutical industry has hit back strongly at the recent tariff announcement by U.S. President Donald Trump, calling it a move that could hurt the American healthcare system more than India's economy. …
- Piramal Pharma Limited Announces Results for Q1FY26 July 28, 2025 7:56 pm WFMZ - Pennsylvania MUMBAI, India, July 28, 2025 /PRNewswire/ -- Piramal Pharma Limited (NSE: PPLPHARMA) (BSE: 543635), a leading global pharmaceutical, and health and wellness company, today announced its standalone and consolidated results for the First Quarter (Q1) …
- Top stocks in news: Kotak Bank, IndusInd Bank, RITES, Dr Reddy's Labs, CDSL, Bank of Baroda, SAIL July 28, 2025 2:46 am Business Today Indian benchmark indices continued to settle lower on Friday on the back of weak global cues and muted corporate earnings by India Inc. BSE Sensex crashed 542.47 points, or 0.66 per cent, to settle at 82,184.17, while NSE's Nifty50 tanked 157.80 points …
- Big Pharma’s New Chapter: M&A, Metabolism &the Outsourcing Boom July 24, 2025 11:11 am Contract Pharma The year 2024 was a study in contrasts for the pharmaceutical industry. Total drug sales largely rebounded as the pandemic waned, yet growth came unevenly—colossal revenue windfalls from COVID-19 products faded, even as new blockbuster therapies, notably …
- Small-cap pharma stock Blue Jet Healthcare falls 7%, crashes 17% in 3 days; time to buy? July 23, 2025 9:16 am Mint A small-cap pharma stock is witnessing intense selling pressure after the release of its Q1 results. Blue Jet Healthcare share price crashed over 7 per cent in intraday trade on the BSE on Wednesday, July 23, falling almost 17 per cent in three days. The …
- Aptar acquires Mod3 Pharma’s trial materials manufacturing capabilities July 17, 2025 4:56 pm Clinical Trials Arena Aptar Pharma has announced the acquisition of Mod3 Pharma’s clinical trial materials manufacturing capabilities from SWK Holdings. Mod3 Pharma was previously known as Enteris Biopharma. This acquisition is a strategic move aimed at strengthening Aptar …
- Nigeria targets $10 billion pharma sector to boost medicine security July 11, 2025 3:18 pm Premium Times As Nigeria seeks to secure its medicine supply and reduce dependence on imports, the pharmaceutical industry is targeting a tenfold expansion, projecting growth from an estimated $2 billion to $10 billion within the next five years. This ambition, driven …
- Nigeria Pharma Industry Targets $10bn, Medicine Security July 10, 2025 5:53 am Leadership The Association of Community Pharmacists of Nigeria (ACPN) has said that the pharmaceutical industry is on the path to transformative growth as local manufacturers and investors channel multi-million-dollar investments into Active Pharmaceutical Ingredient …
- From Laurus Labs, Lupin to Biocon— Pharma stocks rise up to 3% despite Trump's 200% tariff threat July 9, 2025 5:13 am Mint Pharma stocks exhibited remarkable resilience in the morning trade on Wednesday, July 9, despite US President Donald Trump's threat of a very high tariff of up to 200 per cent. Several pharma stocks, including Laurus Labs, Lupin, Biocon, Cipla and Divi …
- Pharma Stocks Slide Up To 3% On US Tariff Concerns; Aurobindo, DRL, Lupin Among Top Losers July 8, 2025 9:14 am News18 Last Updated:July 08, 2025, 12:48 IST Shares of Indian pharma companies fell on July 8 as investor concerns resurfaced following US President Trump’s announcement of new tariff Indian pharma stocksPharma Stocks Fall: Shares of Indian pharma companies fell …
- European Commission fines Alchem for role in pharma cartel July 7, 2025 6:59 pm ICLG Penalty concludes lengthy investigation into price-fixing and other cartelist behaviour involving seven p... Penalty concludes lengthy investigation into price-fixing and other cartelist behaviour involving seven pharmaceutical manufacturers. The European …
- How US Tariffs Could Disrupt The Generic Drugs Supply Chain July 1, 2025 8:55 am MENAFN (MENAFN- Swissinfo) Generic drugs run on thin margins and tight supply chains. Any disruption triggered by increased tariffs could raise prices, push some manufacturers out of the market and even worsen medicine shortages. This content was published on …
- UP’s Much-Awaited Pharma Park All Set To Become A Reality By 2027 June 30, 2025 6:43 pm News18 Last Updated:June 30, 2025, 15:49 IST With construction underway on over 350 acres in the first phase, the project is expected to catalyse investments worth over Rs 12,000 crore With construction in full swing, the park is expected to show physical results …
- US trade tariffs and the potential impact on pharma supply chains June 30, 2025 6:24 pm Pharmaceutical Technology When Donald Trump was elected the 47th president of the United States of America, the outlook for pharmaceuticals was unclear, with 55% of North American industry professionals expecting negative repercussions when surveyed by GlobalData later that month. …
- CPHI & PMEC China 2025: Asia’s pharma powerhouse strengthens global linkages June 26, 2025 4:24 am Biospectrum Asia CPHI & PMEC China 2025: Asia’s pharma powerhouse strengthens global linkages June 26, 2025 | Thursday | News | By Special Coverage by| Saradha Mani , BioSpectrum Asia Asia’s largest pharmaceutical exhibition hosted over 90,000 participants, 3,500+ …
- EVA Pharma and CHICO Pharmaceutical unite to localise oncology API production for the Middle East and Africa June 24, 2025 12:09 pm Biospectrum Asia EVA Pharma and CHICO Pharmaceutical unite to localise oncology API production for the Middle East and Africa June 24, 2025 | Tuesday | News | By Ankit Kankar | ankit.kankar@mmactiv.com Strategic MoU signed at CPHI China 2025 aims to strengthen regional …